1. Davidson, J., K. Lloyd, J. Dankova, andO. Hornykiewicz: L-dopa treatment in Parkinson's Disease: Effect on dopamine and related substances in discrete brain regions. Experientia27, 1048?1049 (1971).
2. Romero, J. A., L. D. Lytle, L. A. Ordonez, andR. J. Wurtman: Effects of 1-dopa administration on the concentrations of dopa, dopamine, and norepinephrine in various rat tissues. J. Pharmacol. Exper. Ther. (in press, 1972).
3. Ordonez, L. A., J. A. Romero, andR. J. Wurtman: Tissue distribution of l-dopa: Evidence for a reservoir in muscle. Federation Proceedings31, 589 (1972).
4. Carlsson, A., andB. Waldeck: On the role of liver catechol-O-methyl transferase in metabolism of circulating catecholamines. Acta Pharmacol. Toxicol. (Kobenhavn)20, 47?55 (1963).
5. Anton, A. H., andD. F. Sayre: A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines. J. Pharmacol. Exper. Ther.138, 360?375 (1962).